Jeff Fairman, VP, Research at Vaxcyte, Inc. (PCVX), sold 15,000 shares at $25.50 ($384K) on 2022-08-04, disclosed to the SEC on 2022-08-05.
Open-market sale of $384k PCVX by VP, Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.50 | 10,000 | $255K | 66.5% |
| 2 | $25.70 | 5,000 | $129K | 33.5% |
| Total | $25.57 avg | 15,000 | $384K | 100% |
| Filing → |
| PCVX | SELL | 2022-09-07 | $257K | — | Filing → |
| PCVX | SELL | 2022-05-24 | $105K | — | Filing → |
| PCVX | SELL | 2022-05-09 | $23K | — | Filing → |